These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

90 related articles for article (PubMed ID: 7611781)

  • 1. [Detection of loss of heterozygosity by microsatellite probe and DNA content analysis].
    Chiba W; Sawai S; Ikeda S; Kinoshita M; Hatama T; Shin S; Fujimoto T; Miyajima S; Wazawa H; Hanawa T
    Gan To Kagaku Ryoho; 1995 Jun; 22 Suppl 2():158-63. PubMed ID: 7611781
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Frequent microsatellite alterations on chromosome 3p in esophageal squamous cell carcinoma.
    Ogasawara S; Maesawa C; Tamura G; Satodate R
    Cancer Res; 1995 Feb; 55(4):891-4. PubMed ID: 7850805
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [Significance of heterozygosity loss in the long arm of chromosome 5 (5q21) in small cell carcinoma of the lung].
    Sánchez Céspedes M; López Cabrerizo MP; Moreno I; Ariza A; Monzó M; Rosell R
    Med Clin (Barc); 1997 May; 109(1):1-5. PubMed ID: 9303970
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Sequential loss of heterozygosity at microsatellite motifs in preinvasive and invasive head and neck squamous carcinoma.
    el-Naggar AK; Hurr K; Batsakis JG; Luna MA; Goepfert H; Huff V
    Cancer Res; 1995 Jun; 55(12):2656-9. PubMed ID: 7780981
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Tobacco smoke-induced DNA damage and an early age of smoking initiation induce chromosome loss at 3p21 in lung cancer.
    Hirao T; Nelson HH; Ashok TD; Wain JC; Mark EJ; Christiani DC; Wiencke JK; Kelsey KT
    Cancer Res; 2001 Jan; 61(2):612-5. PubMed ID: 11212258
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [p53 alterations and chromosome 17 aberrations in non-small cell lung cancer].
    Tsuji T; Tagawa Y; Hisamatsu T; Nakamura S; Terada R; Sawai T; Yasutake T; Ayabe H
    Gan To Kagaku Ryoho; 1997 Jul; 24 Suppl 2():263-8. PubMed ID: 9263513
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [Detailed mapping and clinical significance of loss of heterozygosity on 9p13-23 in laryngeal squamous cell carcinoma by microsatellite analysis].
    Xu XF; Tang PZ; Cheng SJ
    Ai Zheng; 2003 May; 22(5):452-7. PubMed ID: 12753701
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Multiple high-grade bronchial dysplasia and squamous cell carcinoma: concordant and discordant mutations.
    Boyle JO; Lonardo F; Chang JH; Klimstra D; Rusch V; Dmitrovsky E
    Clin Cancer Res; 2001 Feb; 7(2):259-66. PubMed ID: 11234877
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Loss of heterozygosity on chromosomes 10 and 17 in clinically localized prostate carcinoma.
    Ittmann MM
    Prostate; 1996 May; 28(5):275-81. PubMed ID: 8610052
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Analysis of replication error (RER+) phenotypes in cervical carcinoma.
    Larson AA; Kern S; Sommers RL; Yokota J; Cavenee WK; Hampton GM
    Cancer Res; 1996 Mar; 56(6):1426-31. PubMed ID: 8640835
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Minimal commonly deleted regions on chromosome 7q31 in primary gastric carcinoma and its clinical significance].
    Li JT; Fu L; Xia JC; Feng BJ; Mai SJ; Yu XJ; Huang LX; Feng QS; Pan ZZ; Zhan YQ
    Ai Zheng; 2005 Nov; 24(11):1306-11. PubMed ID: 16552953
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Studies of microsatellite instability and loss of heterozygosity at chromosome 17 in non-small cell lung carcinoma].
    Guo X; Ni P; Li L
    Zhonghua Jie He He Hu Xi Za Zhi; 1999 Dec; 22(12):743-5. PubMed ID: 11776784
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Loss of heterozygosity of chromosome 3p21 is associated with mutant TP53 and better patient survival in non-small-cell lung cancer.
    Marsit CJ; Hasegawa M; Hirao T; Kim DH; Aldape K; Hinds PW; Wiencke JK; Nelson HH; Kelsey KT
    Cancer Res; 2004 Dec; 64(23):8702-7. PubMed ID: 15574780
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Loss of heterozygosity at chromosome 3p14, 25 in serum DNA from ovarian cancer patients].
    Zhang H; Li Z; Chen M; Zhang G; Xu K
    Zhonghua Fu Chan Ke Za Zhi; 2002 May; 37(5):298-300. PubMed ID: 12133406
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Loss of heterozygosity at 3p in non-small cell lung cancer and its prognostic implication.
    Mitsudomi T; Oyama T; Nishida K; Ogami A; Osaki T; Sugio K; Yasumoto K; Sugimachi K; Gazdar AF
    Clin Cancer Res; 1996 Jul; 2(7):1185-9. PubMed ID: 9816286
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Loss of heterozygosity for chromosome 11 in adenocarcinoma of the stomach.
    Baffa R; Negrini M; Mandes B; Rugge M; Ranzani GN; Hirohashi S; Croce CM
    Cancer Res; 1996 Jan; 56(2):268-72. PubMed ID: 8542579
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Loss of heterozygosity studies on chromosome 17 in head and neck cancer using microsatellite markers.
    Adamson R; Jones AS; Field JK
    Oncogene; 1994 Jul; 9(7):2077-82. PubMed ID: 8208554
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Fine deletion mapping on chromosome 8p21 - 8p22 in adenocarcinoma of lung].
    Shao S; Sun W; Zhang J; An Q; Xiao T; Yang P; Cheng S; Gao Y
    Zhonghua Yi Xue Za Zhi; 2002 Jun; 82(11):740-2. PubMed ID: 12126542
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Loss of heterozygosity on chromosomes 2p, 3p, 18q21.3 and 11p15.5 as a poor prognostic factor in stage II and III (FIGO) cervical cancer treated by radiotherapy.
    Kozlowski L; Filipowski T; Rucinska M; Pepinski W; Janica J; Skawronska M; Poznanski J; Wojtukiewicz MZ
    Neoplasma; 2006; 53(5):440-3. PubMed ID: 17013540
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Genomic alterations and instabilities in renal cell carcinomas and their relationship to tumor pathology.
    Thrash-Bingham CA; Salazar H; Freed JJ; Greenberg RE; Tartof KD
    Cancer Res; 1995 Dec; 55(24):6189-95. PubMed ID: 8521412
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.